ALNOVNovacyt S.A.
0.5350EUR+9.18%Mkt Cap: 41.85M $P/E:

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmenta…

Key Statistics

Company
Market Cap41.85M $
Enterprise Value28.03M $
Revenue (TTM)21.77M $
Gross Profit13.71M $
Net Income (TTM)-24.87M $
Revenue/Share0.3087 USD
Last Price0.5350 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees216
CountryFR
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)1.88
PEG
EV/EBITDA9.95
EV/Revenue1.29
P/S1.77
P/B1.27
EPS (TTM)-0.39
EPS (Forward)0.26
52W Range
0.476575% of range0.5550
52W High0.5550 EUR
52W Low0.4765 EUR
Profitability
Gross Margin62.98%
Oper. Margin-59.36%
EBITDA Margin12.95%
Profit Margin-114.25%
ROE-97.91%
ROA-56.74%
Growth
Revenue Growth6.00%
Earnings Growth
Cash Flow & Leverage
Operating CF-9.79M $
CapEx (TTM)957.61K $
FCF Margin36.82%
FCF Yield19.16%
Net Debt-9.58M $
Net Debt/EBITDA-3.40
Balance Sheet
Debt/Equity0.45
Current Ratio4.75
Quick Ratio4.16
Book Value/Sh0.3872 EUR
Cash/Share0.2730 EUR
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 EUR
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.72.50M
Float70.41M
Insiders0.06%
Institutions0.00%
Technical
SMA 500.4345 (+23.1%)
SMA 2000.4302 (+24.4%)
Beta1.11
S&P 52W Chg18.16%
Avg Vol (30d)479.25K
Avg Vol (10d)562.07K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)